Innovenn

Innovenn is a woman-owned healthcare consulting firm established in 2014 that specializes in navigating regulatory approval processes for pharmaceutical companies, medical device manufacturers, and digital health innovators. Based in Madison, Wisconsin, the company brings over 250 collective years of experience across its team to help clients design, develop, validate, and secure regulatory approvals for healthcare innovations.

The firm provides comprehensive services spanning the product lifecycle, including Software as a Medical Device (SaMD) development, medical device development consulting, human factors and usability engineering, regulatory planning and submissions, drug development consulting, quality management systems implementation, and program management. Innovenn has supported over 300 IND, NDA, 510(k), De Novo, and PMA submissions to regulatory authorities.

The company positions itself around enabling precision medicine through patient-centered design approaches. Innovenn emphasizes early patient engagement and diverse stakeholder input throughout the development process to create innovations that address genuine unmet needs in healthcare.

Choose Innovenn when your organization needs specialized regulatory guidance for complex FDA submissions, particularly for novel medical devices, SaMD products, or precision medicine innovations. Their combination of regulatory expertise and patient-centered design methodology makes them particularly valuable for products where human factors validation and usability engineering are critical to approval.

Expect a consultative partnership where Innovenn integrates regulatory strategy with business and clinical objectives. Their lean approach emphasizes getting regulatory work right the first time, with quality management systems aligned to U.S. and international standards throughout project execution.

Innovenn exclusively serves the healthcare and life sciences sector with 100% focus on pharmaceutical, medical device, and digital health clients. The firm specializes in navigating FDA regulatory pathways specific to healthcare products, including IND and NDA submissions for drugs, 510(k), De Novo, and PMA pathways for medical devices, and regulatory frameworks for Software as a Medical Device (SaMD) and digital therapeutics.

Their healthcare expertise extends to quality management systems compliant with ISO standards for medical devices, human factors engineering aligned with FDA guidance documents, and precision medicine approaches that leverage patient-specific data for diagnosis and treatment optimization.

Ideal clients are mid-stage pharmaceutical companies, medical device manufacturers, or venture-backed digital health startups developing innovative products requiring FDA clearance or approval. Organizations benefit most when they need both regulatory expertise and patient-centered design input, particularly for novel device categories, SaMD applications, or precision medicine innovations where human factors validation is critical to success.